Cosmo Smith on The Breakthrough Oncology Accelerator Flagship Program

P. Cosmo Smith, MBA
Published: Wednesday, Oct 17, 2018



P. Cosmo Smith, MBA, managing partner, Origin Commercial Ventures, discusses The Breakthrough Oncology Accelerator flagship program.

Origin is one of the founding members of The Breakthrough Oncology Accelerator flagship program, notes Smith. Their role is in building and growing the financial components of the partnership with Atlantic Health and Translational Genomics Research Institute (TGen). By creating and financing new payment models, more patients will be able to access novel therapies moving forward, explains Smith.

Origin identifies as a global partner to Atlantic Health and TGen, adds Smith. By overseeing the business and financial strategies of the partnership, Origin hopes to expand their ability to bring novel therapies to patients, aid in identifying the right patients to receive the right therapies, and create new monitoring programs that work best in real time to ensure the deliverance of those therapies.
SELECTED
LANGUAGE


P. Cosmo Smith, MBA, managing partner, Origin Commercial Ventures, discusses The Breakthrough Oncology Accelerator flagship program.

Origin is one of the founding members of The Breakthrough Oncology Accelerator flagship program, notes Smith. Their role is in building and growing the financial components of the partnership with Atlantic Health and Translational Genomics Research Institute (TGen). By creating and financing new payment models, more patients will be able to access novel therapies moving forward, explains Smith.

Origin identifies as a global partner to Atlantic Health and TGen, adds Smith. By overseeing the business and financial strategies of the partnership, Origin hopes to expand their ability to bring novel therapies to patients, aid in identifying the right patients to receive the right therapies, and create new monitoring programs that work best in real time to ensure the deliverance of those therapies.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication
x